| Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma AP Patel, I Tirosh, JJ Trombetta, AK Shalek, SM Gillespie, H Wakimoto, ... Science 344 (6190), 1396-1401, 2014 | 4852 | 2014 |
| An integrative model of cellular states, plasticity, and genetics for glioblastoma C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ... Cell 178 (4), 835-849. e21, 2019 | 2112 | 2019 |
| Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells ML Suvà, E Rheinbay, SM Gillespie, AP Patel, H Wakimoto, SD Rabkin, ... Cell 157 (3), 580-594, 2014 | 989 | 2014 |
| Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq AS Venteicher, I Tirosh, C Hebert, K Yizhak, C Neftel, MG Filbin, ... Science 355 (6332), eaai8478, 2017 | 958 | 2017 |
| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy LS Sasportas, R Kasmieh, H Wakimoto, S Hingtgen, JAJM van de Water, ... Proceedings of the national academy of sciences 106 (12), 4822-4827, 2009 | 591 | 2009 |
| Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors RL Flynn, KE Cox, M Jeitany, H Wakimoto, AR Bryll, NJ Ganem, F Bersani, ... Science 347 (6219), 273-277, 2015 | 545 | 2015 |
| Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance BB Liau, C Sievers, LK Donohue, SM Gillespie, WA Flavahan, TE Miller, ... Cell stem cell 20 (2), 233-246. e7, 2017 | 530 | 2017 |
| CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity BD Choi, X Yu, AP Castano, AA Bouffard, A Schmidts, RC Larson, ... Nature biotechnology 37 (9), 1049-1058, 2019 | 498 | 2019 |
| Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion K Tateishi, H Wakimoto, AJ Iafrate, S Tanaka, F Loebel, N Lelic, ... Cancer cell 28 (6), 773-784, 2015 | 458 | 2015 |
| Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors H Wakimoto, S Kesari, CJ Farrell, WT Curry Jr, C Zaupa, M Aghi, T Kuroda, ... Cancer research 69 (8), 3472-3481, 2009 | 428 | 2009 |
| Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma T Hara, R Chanoch-Myers, ND Mathewson, C Myskiw, L Atta, L Bussema, ... Cancer cell 39 (6), 779-792. e11, 2021 | 409 | 2021 |
| Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses K Ikeda, T Ichikawa, H Wakimoto, JS Silver, TS Deisboeck, D Finkelstein, ... Nature medicine 5 (8), 881-887, 1999 | 408 | 1999 |
| Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016 | 355 | 2016 |
| TWIST1 promotes invasion through mesenchymal change in human glioblastoma SA Mikheeva, AM Mikheev, A Petit, R Beyer, RG Oxford, L Khorasani, ... Molecular cancer 9, 1-18, 2010 | 333 | 2010 |
| An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma E Rheinbay, ML Suvà, SM Gillespie, H Wakimoto, AP Patel, M Shahid, ... Cell reports 3 (5), 1567-1579, 2013 | 331 | 2013 |
| Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis ND Mathewson, O Ashenberg, I Tirosh, S Gritsch, EM Perez, S Marx, ... Cell 184 (5), 1281-1298. e26, 2021 | 320 | 2021 |
| Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells H Wakimoto, G Mohapatra, R Kanai, WT Curry, S Yip, M Nitta, AP Patel, ... Neuro-oncology 14 (2), 132-144, 2011 | 274 | 2011 |
| Brain tumor cells in circulation are enriched for mesenchymal gene expression JP Sullivan, BV Nahed, MW Madden, SM Oliveira, S Springer, D Bhere, ... Cancer discovery 4 (11), 1299-1309, 2014 | 264 | 2014 |
| In Vivo Gene Therapy for α-Fetoprotein-producing Hepatocellular Carcinoma by Adenovirus-mediated Transfer of Cytosine Deaminase Gene F Kanai, KH Lan, Y Shiratori, T Tanaka, M Ohashi, T Okudaria, Y Yoshida, ... Cancer research 57 (3), 461-465, 1997 | 248 | 1997 |
| Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model TA Cheema, H Wakimoto, PE Fecci, J Ning, T Kuroda, DS Jeyaretna, ... Proceedings of the National Academy of Sciences 110 (29), 12006-12011, 2013 | 231 | 2013 |
